The Center for High-Throughput Functional Annotation of Natural Products unites the natural products chemistry, biological screening, data analytics and bioinformatic strengths of UTSW and UC Santa Cruz to generate a center for natural products research that can use innovative strategies to study the biological effects of botanicals and natural products. Our deliverables will orthogonal data sets that will allow predictions and validation of mechanism of action for libraries of botanicals and natural products. We intend for this to be a significant resource with long-term value for the botanical, natural product and biomedical research communities. Prosecution of this goal requires extensive interaction and collaboration within and among internal and external multidisciplinary teams. This includes integration of the UTSW and UCSC research teams, interaction with other CANPIT centers and ODS Botanical Centers, and meeting the data standards, information scale, and data sharing expectations of the CANPIT program. As such an administrative core is essential to 1) organize and maintain a framework for effective collaborative interaction within Center; 2) establish and maintain program oversight to enable compliance with metadata quality standards, public data release of data, and other NIH grants governance and reporting standards; and 3) facilitate monthly and yearly meetings of the scientific team and an external advisory board.

Public Health Relevance

statement: The overarching goal of the Administrative component is to provide leadership and general administration for all activities related to the Center for High-Throughput Functional Annotation of Natural Products and to the overall CANPIT program. The administrative component is responsible for integrating the data generation team, data analytics team and community outreach team into a unified multidisciplinary approach for a greater understanding of the chemical/biological relationships of botanicals and natural products.

Agency
National Institute of Health (NIH)
Institute
National Center for Complementary & Alternative Medicine (NCCAM)
Type
Biotechnology Resource Cooperative Agreements (U41)
Project #
1U41AT008718-01
Application #
8881712
Study Section
Special Emphasis Panel (ZAT1-SM (35))
Project Start
2015-09-01
Project End
2020-06-30
Budget Start
2015-09-01
Budget End
2016-06-30
Support Year
1
Fiscal Year
2015
Total Cost
$54,046
Indirect Cost
$20,581
Name
University of Texas Sw Medical Center Dallas
Department
Type
DUNS #
800771545
City
Dallas
State
TX
Country
United States
Zip Code
75390
Kalwat, Michael A; Hwang, In Hyun; Macho, Jocelyn et al. (2018) Chromomycin A2 potently inhibits glucose-stimulated insulin secretion from pancreatic ? cells. J Gen Physiol 150:1747-1757
Pye, Cameron R; Bertin, Matthew J; Lokey, R Scott et al. (2017) Reply to Skinnider and Magarvey: Rates of novel natural product discovery remain high. Proc Natl Acad Sci U S A 114:E6273
Vaden, Rachel M; Oswald, Nathaniel W; Potts, Malia B et al. (2017) FUSION-Guided Hypothesis Development Leads to the Identification of N?,N?-Dimethyladenosine, a Marine-Derived AKT Pathway Inhibitor. Mar Drugs 15:
Pye, Cameron R; Bertin, Matthew J; Lokey, R Scott et al. (2017) Retrospective analysis of natural products provides insights for future discovery trends. Proc Natl Acad Sci U S A 114:5601-5606
Kalwat, Michael A; Wichaidit, Chonlarat; Nava Garcia, Alejandra Y et al. (2016) Insulin promoter-driven Gaussia luciferase-based insulin secretion biosensor assay for discovery of ?-cell glucose-sensing pathways. ACS Sens 1:1208-1212